Enhanced expression of leptin and its receptors has a positive association with the risk of breast,39, 50 endometrial,41, 51 colorectal,52 gastric,35, 40 ovarian,53 and upper tract urothelial carcinomas.54 This evidence concerns the gene LEP and renal pelvis/ureter urothelial carcinoma.